Franklin Resources’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3M | Sell |
2,732,777
-28,990
| -1% | -$406K | 0.01% | 710 |
|
|
2025
Q1 | $43.2M | Sell |
2,761,767
-547,552
| -17% | -$8.56M | 0.01% | 651 |
|
|
2024
Q4 | $46.1M | Sell |
3,309,319
-941,099
| -22% | -$13.1M | 0.01% | 641 |
|
|
2024
Q3 | $41.4M | Sell |
4,250,418
-187,761
| -4% | -$1.83M | 0.01% | 666 |
|
|
2024
Q2 | $41.3M | Sell |
4,438,179
-204,281
| -4% | -$1.9M | 0.01% | 605 |
|
|
2024
Q1 | $46M | Sell |
4,642,460
-13,084
| -0.3% | -$130K | 0.01% | 594 |
|
|
2023
Q4 | $15M | Buy |
4,655,544
+3,363,191
| +260% | +$10.9M | 0.01% | 825 |
|
|
2023
Q3 | $6.86M | Sell |
1,292,353
-360,183
| -22% | -$1.91M | ﹤0.01% | 996 |
|
|
2023
Q2 | $15.7M | Buy |
1,652,536
+59,166
| +4% | +$564K | 0.01% | 831 |
|
|
2023
Q1 | $17.5M | Buy |
1,593,370
+795,634
| +100% | +$8.75M | 0.01% | 809 |
|
|
2022
Q4 | $11.8M | Sell |
797,736
-1,260
| -0.2% | -$18.6K | 0.01% | 902 |
|
|
2022
Q3 | $15.3M | Buy |
798,996
+5,100
| +0.6% | +$97.5K | 0.01% | 841 |
|
|
2022
Q2 | $16.9M | Buy |
793,896
+134,060
| +20% | +$2.86M | 0.01% | 829 |
|
|
2022
Q1 | $12.7M | Buy |
659,836
+44,091
| +7% | +$849K | 0.01% | 955 |
|
|
2021
Q4 | $12.8M | Buy |
615,745
+40,537
| +7% | +$841K | ﹤0.01% | 989 |
|
|
2021
Q3 | $13.7M | Sell |
575,208
-520
| -0.1% | -$12.4K | 0.01% | 984 |
|
|
2021
Q2 | $15.7M | Sell |
575,728
-77,280
| -12% | -$2.11M | 0.01% | 920 |
|
|
2021
Q1 | $18.9M | Buy |
+653,008
| New | +$18.9M | 0.01% | 847 |
|